tiprankstipranks
pc:opene

OpenEvidence

Cambridge, Massachusetts, United States
www.openevidence.com
Digital Health
OpenEvidence is a leading medical search and AI application platform widely utilized by verified U.S. clinicians. The company recently launched OpenEvidence DeepConsult™, an AI agent specifically designed to support physicians in their practice. Based in Cambridge, Massachusetts, OpenEvidence focuses on enhancing clinical decision-making through advanced artificial intelligence solutions.

Leadership & Board

Key Executives
Co-Founder and CTOZachary Ziegler
FounderDaniel Nadler
Current Number of Employees113
Current LinkedIn Followers38,800

Latest Estimated Valuation

Estimated Valuation$12B
Estimated Valuation$12B
Total Amount Raised$560M
Total Amount Raised$560M
Total Funding Rounds3
Total Funding Rounds3
Latest Funding Amount$250M
Latest Funding Amount$250M
Latest Funding RoundSeries D
Latest Funding RoundSeries D
Post-Money Valuation$12B
Post-Money Valuation$12B

Company Momentum Positive

Articles Published on TipRanks6
Articles Published on TipRanks
6
LinkedIn Trend+2.72% followers
LinkedIn Trend
+2.72% followers
Workforce Trend+0.9% employees
Workforce Trend
+0.9% employees
OpenEvidence LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Company Momentum indicates whether the company is gaining or losing traction over time. This proprietary TipRanks metric analyzes changes in a company’s workforce and LinkedIn follower trends, balancing these signals together to generate an overall momentum sentiment.

Employee Trend

OpenEvidence had 113 employees as of May 4, 2026. The number of employees increased by 1 (0.89%) week-over-week.
113Latest Employee Count
1(0.89%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

OpenEvidence had 38,800 followers as of May 4, 2026. The number of followers increased by 1K (2.72%) week-over-week.
38,800Latest Followers Count
1K(2.72%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 21, 2026
Series D
$250.00M
$12.00B
Jul 15, 2025
Series B
$210.00M
$3.50B
Feb 20, 2025
Series A
$100.00M
$1.00B

Investors

Investor Name
Funding Round
Sequoia Capital
Series A
Sequoia Capital
Series B
Kleiner Perkins
Series B
Google Ventures
Series B
Coatue
Series B
Conviction
Series B
Thrive
Series B
Kleiner Perkins
Series D

Related News and Analysis

OpenEvidence Expands Clinical AI Footprint With AUA and NCCN Guideline Integrations

OpenEvidence Expands Clinical AI Footprint With AUA and NCCN Guideline Integrations

OpenEvidence advanced its position in AI-enabled clinical decision support this week through guideline partnerships in both urology and...
2d ago
OPENE
OpenEvidence Partners With American Urological Association on AI-Enabled Guideline Integration

OpenEvidence Partners With American Urological Association on AI-Enabled Guideline Integration

According to a recent LinkedIn post from OpenEvidence, the company is entering a partnership with the American Urological...
4d ago
OPENE
OpenEvidence Integrates AUA Guidelines Into AI Clinical Platform

OpenEvidence Integrates AUA Guidelines Into AI Clinical Platform

According to a recent LinkedIn post from OpenEvidence, the company is integrating American Urological Association Clinical Practice Guidelines...
4d ago
OPENE
OpenEvidence Strikes Multi-Year Deal to Embed AUA Guidelines in Its AI Clinical Platform

OpenEvidence Strikes Multi-Year Deal to Embed AUA Guidelines in Its AI Clinical Platform

New updates have been reported about OpenEvidence. OpenEvidence has signed a multi-year collaboration with the American Urological Association...
4d ago
OPENE
OpenEvidence Deepens Oncology Decision-Support With NCCN Guideline Integration

OpenEvidence Deepens Oncology Decision-Support With NCCN Guideline Integration

According to a recent LinkedIn post from OpenEvidence, the company is now incorporating National Comprehensive Cancer Network (NCCN)...
7d ago
OPENE
OpenEvidence Enhances Oncology Decision Support With NCCN Guidelines Integration

OpenEvidence Enhances Oncology Decision Support With NCCN Guidelines Integration

According to a recent LinkedIn post from OpenEvidence, the company has incorporated National Comprehensive Cancer Network (NCCN) Clinical...
7d ago
OPENE
OpenEvidence Deepens Wiley Partnership With Neurology Society Content

OpenEvidence Deepens Wiley Partnership With Neurology Society Content

According to a recent LinkedIn post from OpenEvidence, the company is expanding its collaboration with publisher Wiley to...
17d ago
OPENE
OpenEvidence Deepens Neurology Content Through Expanded Wiley Partnership

OpenEvidence Deepens Neurology Content Through Expanded Wiley Partnership

According to a recent LinkedIn post from OpenEvidence, the company is expanding its collaboration with Wiley to incorporate...
17d ago
OPENE
Physician Testimonial Highlights OpenEvidence’s AI Role in Primary Care Workflow

Physician Testimonial Highlights OpenEvidence’s AI Role in Primary Care Workflow

According to a recent LinkedIn post from OpenEvidence, the company is highlighted in a physician’s testimonial describing how...
21d ago
OPENE
OpenEvidence Highlights Heavy Physician Usage and AI Infrastructure Partnership

OpenEvidence Highlights Heavy Physician Usage and AI Infrastructure Partnership

According to a recent LinkedIn post from OpenEvidence, the company’s clinical information platform is being used to answer...
1M ago
OPENE